Abstract
Background/Aims: The roles of inflammatory and fibrogenic biomarkers in chronic hepatitis B (CHB) infection and hepatitis B virüs (HBV)-related cirrhosis remain incompletely understood. The current study investigated the diagnostic and discriminative ability of amphiregulin (AREG), interleukin-6 (IL-6), and neuropilin-1 (Nrp-1) as biomarkers of HBV-related cirrhosis.
Materials and Methods: This cross-sectional analytical study included 70 patients with CHB (43 without cirrhosis and 27 with HBVrelated cirrhosis) and 60 healthy controls. Clinical and laboratory data were obtained from hospital records. Serum IL-6, Nrp-1, and AREG levels collected during outpatient visits were measured using enzyme-linked immunosorbent assay. Group differences were analyzed using the Kruskal–Wallis test, discriminative performance was evaluated using receiver operating characteristic (ROC) analysis, and factors independently associated with cirrhosis were identified using logistic regression.
Results: IL-6 and Nrp-1 levels were higher in patients with noncirrhotic and HBV-related cirrhotic CHB than in healthy controls (P < .001), with no significant difference between the patient subgroups. AREG levels were lower in the overall CHB cohort than in controls (P < .001) but higher in patients with cirrhosis than in those without cirrhosis (P = .001). ROC analysis showed that AREG had moderate discriminative ability for HBV-related cirrhosis (area under the curve (AUC) = 0.749). The optimal Youden-derived cutoff value was 2.29 ng/mL, with a sensitivity of 74% and a specificity of 65%. In logistic regression, AREG was independently associated with HBV-related cirrhosis (P = .012). Addition of ln-transformed AREG to age- and sex-adjusted aspartate aminotransferase-to-platelet ratio index (APRI)- and Fibrosis-4 index (FIB-4)-based models increased the AUC from 0.923 to 0.970 and from 0.938 to 0.980, respectively.
Conclusion: AREG may serve as a complementary biomarker with moderate discriminative value for HBV-related cirrhosis but is unlikely to be useful as a standalone diagnostic or prognostic marker. Although IL-6 and Nrp-1 reflected underlying inflammatory activity, their ability to distinguish cirrhosis was limited.
Cite this article as: Karakoc Ozudogru F, Karaca B, Turker N, et al. Discriminative role of interleukin-6, neuropilin-1, and amphiregulin for cirrhosis in patients with chronic hepatitis B infection. Turk J Gastroenterol. 2026;37(9):985-994.
Most read articles by the same author(s)
- Tansu Yamazhan, İlker Turan, Galip Ersöz, Fulya Günşar, Hüsnü Pullukçu, Nilay Danış, Nalan G. Ünal, Rukiye Vardar, Nevin Oruç, Fatih Tekin, Meltem Taşbakan, Oğuz R. Sipahi, Ulus S. Akarca, Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey , Turkish Journal of Gastroenterology: Vol. 31 No. 3 (2020): Turkish Journal of Gastroenterology
- Ahmet AYDIN, Fulya GÜNŞAR, Mustafa YILMAZ, Zeki KARASU, Ömer ÖZÜTEMİZ, Tankut İLTER, Müge TUNÇYÜREK, Ranitidine bismuth citrate based dual and triple therapies in Helicobacter pylori eradication , Turkish Journal of Gastroenterology: Vol. 10 No. 3 (1999): Turkish Journal of Gastroenterology
- Sinan AKAY, Zeki KARASU, Galip ERSÖZ, Murat KILIÇ, Murat AKYILDIZ, Fulya GÜNŞAR, Ulus AKARCA, Yücel BATUR, Tankut İLTER, Results of endoscopic management of anastomotic biliary strictures after orthotopic liver transplantation , Turkish Journal of Gastroenterology: Vol. 17 No. 3 (2006): Turkish Journal of Gastroenterology
- Mustafa YILMAZ, Ahmet AYDIN, Zeki KARASU, Fulya GÜNŞAR, Ömer ÖZÜTEMİZ, Risk factors associated with changes in oxygenation and pulse rate during colonoscopy , Turkish Journal of Gastroenterology: Vol. 13 No. 4 (2002): Turkish Journal of Gastroenterology
- Galip ERSÖZ, Rukiye Vardar, Ulus Salih AKARCA, Fatih TEKİN, Funda YILMAZ, Fulya GÜNŞAR, Zeki KARASU, Ornidazole-induced autoimmune hepatitis , Turkish Journal of Gastroenterology: Vol. 22 No. 5 (2011): Turkish Journal of Gastroenterology
- Mustafa YILMAZ, Semiha ÖZKOL, F. Feriha ÖZKAN, Fulya GÜNŞAR, Yücel BATUR, Risk of bacteremia in emergent endoscopic variceal scleroterapy , Turkish Journal of Gastroenterology: Vol. 11 No. 4 (2000): Turkish Journal of Gastroenterology
- Galip ERSÖZ, Fulya GÜNŞAR, Zeki KARASU, Sinan AKAY, Yücel BATUR, Ulus Salih AKARCA, Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment , Turkish Journal of Gastroenterology: Vol. 16 No. 3 (2005): Turkish Journal of Gastroenterology
- Mahmut Arabul, Altay KANDEMİR, Mustafa Çelik, Emrah Alper, Zehra Akpınar, Fatih Aslan, Sezgin VATANSEVER, Belkıs Ünsal, Impact of an information video before colonoscopy on patient satisfaction and anxiety , Turkish Journal of Gastroenterology: Vol. 23 No. 5 (2012): Turkish Journal of Gastroenterology
- Nilay Danis, Husnu Pullukcu, Tansu Yamazhan, Galip Ersoz, Nalan Gülsen Unal, Fulya Gunsar, Ilker Turan, Zeki Karasu, Ulus Salih Akarca, Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Zeki KARASU, Funda YILMAZ, Galip ERSÖZ, Fulya GÜNŞAR, Yücel BATUR, Ulus Salih AKARCA, Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C , Turkish Journal of Gastroenterology: Vol. 12 No. 2 (2001): Turkish Journal of Gastroenterology

This work is licensed under a Creative Commons Attribution 4.0 International License.